A chimeric trivalent Echovirus vaccine designed by loop substitution elicits cross-neutralizing immunity against serotypes 11, 18, and 30
Shuai Jiang(China Pharmaceutical University), Jianmin Wu(Zhejiang Lab), Zhenhua Zheng(Chinese Academy of Sciences), Jianbo Xia(Huazhong University of Science and Technology), Jiahui Wu(China Pharmaceutical University), Heming Li(Key Laboratory of Guangdong Province), Jiaqi Cui(China Pharmaceutical University), Tao Sun(China Pharmaceutical University), Jiahuang Li(China Pharmaceutical University), Tianlun Chen(China Pharmaceutical University), Wu Chunchen(Huazhong University of Science and Technology)
Cited by 0
Related Papers
Extending Viability of Bifidobacterium longum in Chitosan-Coated Alginate Microcapsules Using Emulsification and Internal Gelation Encapsulation Technology
|Frontiers in Microbiology|2019|137
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
|Journal of Hematology & Oncology|2021|131
ZIKV infection activates the IRE1-XBP1 and ATF6 pathways of unfolded protein response in neural cells
|Journal of Neuroinflammation|2018|105
Association between serum leptin levels and breast cancer risk
|Medicine|2018|103
Educational Data Mining Techniques for Student Performance Prediction: Method Review and Comparison Analysis
|Frontiers in Psychology|2021|103